Technology
Qudian Inc. Reports Third Quarter 2024 Unaudited Financial Results
Published
11 hours agoon
By
XIAMEN, China, Nov. 22, 2024 /PRNewswire/ — Qudian Inc. (“Qudian” or “the Company” or “We”) (NYSE: QD), a consumer-oriented technology company in China, today announced its unaudited financial results for the quarter ended September 30, 2024.
Third Quarter 2024 Financial Highlights:
Total revenues were RMB55.0 million (US$7.8 million), compared to RMB29.6 million for the same period of last yearNet income attributable to Qudian’s shareholders was RMB131.9 million (US$18.8 million), compared to net loss of RMB181.2 million for the same period of last year; net income per diluted ADS was RMB0.71 (US$0.10) for the third quarter of 2024Non-GAAP net income attributable to Qudian’s shareholders was RMB131.9 million (US$18.8 million), compared to Non-GAAP net loss of RMB179.8 million for the same period of last year. We exclude share-based compensation expenses from our non-GAAP measures. Non-GAAP net income per diluted ADS was RMB0.71 (US$0.10) for the third quarter of 2024
The Company’s last-mile delivery business continued to make steady progress in 2024, which generated approximately RMB53.5 million in revenue in the third quarter of 2024, compared to RMB28.6 million for the third quarter of 2023. Moving forward, the Company expects to remain steadfast in its commitment to executing its business transition and simultaneously maintaining prudent cash management to safeguard its balance sheet.
Third Quarter Financial Results
Sales income and others increased by 85.9% to RMB55.0 million (US$7.8 million) from RMB29.6 million for the third quarter of 2023, which was primarily attributable to the increase in sales income generated from last-mile delivery business.
Total operating costs and expenses decreased to RMB122.0 million (US$17.4 million) from RMB141.1 million for the third quarter of 2023.
Cost of revenues increased by 5.7% to RMB48.9 million (US$7.0 million) from RMB46.3 million for the third quarter of 2023, primarily due to the increase in service cost related to last-mile delivery business.
General and administrative expenses decreased by 27.5% to RMB58.6 million (US$8.3 million) from RMB80.8 million for the third quarter of 2023, primarily due to the reduce in professional services fees after the Company completed research and consultation for last-mile delivery business in its early stage.
Research and development expenses increased by 29.3% to RMB14.6 million (US$2.1 million) from RMB11.3 million for the third quarter of 2023, primarily due to the increase in staff salaries as the Company continues to explore new business opportunities.
Loss from operations was RMB67.0 million (US$9.5 million), compared to RMB100.8 million for the third quarter of 2023.
Interest and investment income, net was RMB228.4 million (US$32.6 million), compared to interest and investment loss of RMB7.1 million for the third quarter of 2023, primarily attributable to the increase of income from investments in the third quarter of 2024.
Gain on derivative instrument was RMB30.2 million (US$4.3 million), compared to loss on derivative instrument of RMB108.0 million for the third quarter of 2023, mainly attributable to the increase in quoted price of the underlying equity securities relating to the derivative instruments we held.
Net income attributable to Qudian’s shareholders was RMB131.9 million (US$18.8 million), compared to net loss attributable to Qudian’s shareholders of RMB181.2 million in the third quarter of 2023. Net income per diluted ADS was RMB0.71 (US$0.10).
Non-GAAP net income attributable to Qudian’s shareholders was RMB131.9 million (US$18.8 million), compared to Non-GAAP net loss attributable to Qudian’s shareholders of RMB179.8 in the third quarter of 2023. Non-GAAP net income per diluted ADS was RMB0.71 (US$0.10).
Cash Flow
As of September 30, 2024, the Company had cash and cash equivalents of RMB4,847.0 million (US$690.7 million) and restricted cash of RMB779.5 million (US$111.1 million). Restricted cash mainly represents security deposits held in designated bank accounts for the guarantee of short-term borrowings. Such restricted cash is not available to fund the general liquidity needs of the Company.
For the third quarter of 2024, net cash provided by operating activities was RMB679.9 million (US$96.9 million), mainly due to the net proceeds from redemption of time and structured deposit. Net cash used in investing activities was RMB541.8 million (US$77.2 million), mainly due to payments of deposit pledged as collateral for derivative instrument. Net cash provided by financing activities was RMB638.0 million (US$90.9 million), mainly due to the proceeds from short-term borrowings and partially offset by the repurchase of ordinary shares.
Last-mile Delivery Business
In response to the surging demand for cross-border e-commerce transactions, the Company has proactively sought innovative logistic services and solutions to meet global consumers’ expectations for swift and top-tier delivery services. In December 2022, the Company launched its last-mile delivery services under the brand name of “Fast Horse.” The business was initially launched on a trial basis and has gradually achieved meaningful scale in Australia during the second quarter of 2023. As of the date of this release, the Company’s last-mile delivery service is available in Australia and New Zealand.
Update on Share Repurchase
Our Board approved a share repurchase program in March 2024 to purchase up to US$300 million worth of Class A ordinary shares or ADSs in the next 36 months starting from June 13, 2024. From the launch of the share repurchase program on June 13, 2024 to November 18, 2024, the Company has in aggregate purchased 12.1 million ADSs in the open market for a total amount of approximately US$25.3 million (an average price of $2.1 per ADS) pursuant to the share repurchase program.
As of November 18, 2024, the Company had in aggregate purchased 166.4 million ADSs for a total amount of approximately US$719.5 million (an average price of $4.3 per ADS).
About Qudian Inc.
Qudian Inc. (“Qudian”) is a consumer-oriented technology company. The Company historically focused on providing credit solutions to consumers. Qudian is exploring innovative logistics services to satisfy consumers’ demand for e-commerce transactions by leveraging its technology capabilities.
For more information, please visit http://ir.qudian.com.
Use of Non-GAAP Financial Measures
We use Non-GAAP net income/loss attributable to Qudian’s shareholders, a Non-GAAP financial measure, in evaluating our operating results and for financial and operational decision-making purposes. We believe that Non-GAAP net income/loss attributable to Qudian’s shareholders helps identify underlying trends in our business by excluding the impact of share-based compensation expenses, which are non-cash charges. We believe that Non-GAAP net income/loss attributable to Qudian’s shareholders provides useful information about our operating results, enhances the overall understanding of our past performance and future prospects and allows for greater visibility with respect to key metrics used by our management in its financial and operational decision-making.
Non-GAAP net income/loss attributable to Qudian’s shareholders is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. This Non-GAAP financial measure has limitations as an analytical tool, and when assessing our operating performance, cash flows or our liquidity, investors should not consider them in isolation, or as a substitute for net loss /income, cash flows provided by operating activities or other consolidated statements of operation and cash flow data prepared in accordance with U.S. GAAP.
We mitigate these limitations by reconciling the Non-GAAP financial measure to the most comparable U.S. GAAP performance measure, all of which should be considered when evaluating our performance.
For more information on this Non-GAAP financial measure, please see the table captioned “Unaudited Reconciliation of GAAP and Non-GAAP Results” set forth at the end of this press release.
Exchange Rate Information
This announcement contains translations of certain RMB amounts into U.S. dollars (“US$”) at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from RMB to US$ were made at the rate of RMB7.0176 to US$1.00, the noon buying rate in effect on September 30, 2024, in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or US$ amounts referred could be converted into US$ or RMB, as the case may be, at any particular rate or at all.
Statement Regarding Preliminary Unaudited Financial Information
The unaudited financial information set out in this earnings release is preliminary and subject to potential adjustments. Adjustments to the consolidated financial statements may be identified when audit work has been performed for the Company’s year-end audit, which could result in significant differences from this preliminary unaudited financial information.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the expectation of its collection efficiency and delinquency, contain forward-looking statements. Qudian may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Qudian’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Qudian’s goal and strategies; Qudian’s expansion plans; Qudian’s future business development, financial condition and results of operations; Qudian’s expectations regarding demand for, and market acceptance of, its products; Qudian’s expectations regarding keeping and strengthening its relationships with customers, business partners and other parties it collaborates with; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Qudian’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Qudian does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
Qudian Inc.
Tel: +86-592-596-8208
E-mail: ir@qudian.com
QUDIAN INC.
Unaudited Condensed Consolidated Statements of Operations
Three months ended September 30,
(In thousands except for number
2023
2024
of shares and per-share data)
(Unaudited)
(Unaudited)
RMB
RMB
US$
Revenues:
Sales income and others
29,598
55,015
7,840
Total revenues
29,598
55,015
7,840
Operating cost and expenses:
Cost of revenues
(46,279)
(48,913)
(6,970)
Sales and marketing
–
(2,123)
(303)
General and administrative
(80,796)
(58,580)
(8,348)
Research and development
(11,277)
(14,576)
(2,077)
Expected credit (loss)/reversal for receivables and other assets
(3,974)
2,798
399
Impairment gain/(loss) from other assets
1,258
(604)
(86)
Total operating cost and expenses
(141,068)
(121,998)
(17,385)
Other operating income
10,668
–
–
Loss from operations
(100,802)
(66,983)
(9,545)
Interest and investment (loss)/income, net
(7,099)
228,420
32,550
Gain/(Loss) from equity method investments
1,010
(1,390)
(198)
(Loss)/Gain on derivative instruments
(107,969)
30,246
4,310
Foreign exchange gain/(loss), net
274
(7,898)
(1,125)
Other income
10,694
2,030
289
Other expenses
(2,157)
(13,809)
(1,968)
Net (loss)/income before income taxes
(206,049)
170,616
24,313
Income tax expenses
24,821
(38,702)
(5,515)
Net (loss)/income
(181,228)
131,914
18,798
Net (loss)/income attributable to Qudian Inc.’s
shareholders
(181,228)
131,914
18,798
(Loss)/Earnings per share for Class A and Class B
ordinary shares:
Basic
(0.84)
0.73
0.10
Diluted
(0.84)
0.71
0.10
(Loss)/Earnings per ADS (1 Class A ordinary share
equals 1 ADSs):
Basic
(0.84)
0.73
0.10
Diluted
(0.84)
0.71
0.10
Weighted average number of Class A and Class B
ordinary shares outstanding:
Basic
214,666,223
180,111,125
180,111,125
Diluted
214,666,223
185,092,607
185,092,607
Other comprehensive loss:
Foreign currency translation adjustment
(1,471)
(60,991)
(8,691)
Total comprehensive (loss)/income
(182,699)
70,923
10,107
Total comprehensive (loss)/income attributable to
Qudian Inc.’s shareholders
(182,699)
70,923
10,107
QUDIAN INC.
Unaudited Condensed Consolidated Balance Sheets
As of June 30,
As of September 30,
(In thousands except for number
2024
2024
of shares and per-share data)
(Unaudited)
(Unaudited)
RMB
RMB
US$
ASSETS:
Current assets:
Cash and cash equivalents
4,849,019
4,847,011
690,694
Restricted cash
51,984
779,529
111,082
Time and structured deposit
2,948,606
1,988,626
283,377
Short-term investments
1,091,177
485,814
69,228
Accounts receivables
39,418
38,492
5,485
Other current assets
615,275
2,104,961
299,955
Total current assets
9,595,479
10,244,433
1,459,821
Non-current assets:
Right-of-use assets
163,246
163,539
23,304
Investment in equity method investee
150,691
148,701
21,190
Long-term investments
210,448
83,987
11,968
Property and equipment, net
1,410,125
1,450,975
206,762
Intangible assets
2,764
1,668
238
Other non-current assets
469,476
459,272
65,446
Total non-current assets
2,406,750
2,308,142
328,908
TOTAL ASSETS
12,002,229
12,552,575
1,788,729
QUDIAN INC.
Unaudited Condensed Consolidated Balance Sheets (Continued)
As of June 30,
As of September 30,
(In thousands except for number
2024
2024
of shares and per-share data)
(Unaudited)
(Unaudited)
RMB
RMB
US$
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings and interest payables
–
720,000
102,599
Short-term lease liabilities
19,789
19,853
2,829
Derivative instruments-liability
248,228
85,795
12,226
Accrued expenses and other current liabilities
202,856
188,209
26,820
Income tax payable
25,947
33,728
4,806
Total current liabilities
496,820
1,047,585
149,280
Non-current liabilities:
Long-term lease liabilities
51,432
51,661
7,362
Total non-current liabilities
51,432
51,661
7,362
Total liabilities
548,252
1,099,246
156,642
Shareholders’ equity:
Class A Ordinary shares
132
132
19
Class B Ordinary shares
44
44
6
Treasury shares
(1,196,636)
(1,263,641)
(180,067)
Additional paid-in capital
4,031,438
4,026,876
573,825
Accumulated other comprehensive loss
14,434
(46,556)
(6,634)
Retained earnings
8,604,565
8,736,474
1,244,938
Total shareholders’ equity
11,453,977
11,453,329
1,632,087
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
12,002,229
12,552,575
1,788,729
QUDIAN INC.
Unaudited Reconciliation of GAAP And Non-GAAP Results
Three months ended September 30,
2023
2024
(In thousands except for number
(Unaudited)
(Unaudited)
of shares and per-share data)
RMB
RMB
US$
Total net (loss)/income attributable to Qudian Inc.’s shareholders
(181,228)
131,914
18,798
Add: Share-based compensation expenses
1,432
–
–
Non-GAAP net (loss)/income attributable to Qudian Inc.’s shareholders
(179,796)
131,914
18,798
Non-GAAP net (loss)/income per share—basic
(0.84)
0.73
0.10
Non-GAAP net (loss)/income per share—diluted
(0.84)
0.71
0.10
Weighted average shares outstanding—basic
214,666,223
180,111,125
180,111,125
Weighted average shares outstanding—diluted
214,666,223
185,092,607
185,092,607
View original content:https://www.prnewswire.com/news-releases/qudian-inc-reports-third-quarter-2024-unaudited-financial-results-302314038.html
SOURCE Qudian Inc.
You may like
Technology
North America’s Optometry Software Market to Grow by USD 576.62 Million (2024-2028), Driven by Rising Ophthalmic Disease Cases, AI Redefining Market Landscape – Technavio
Published
42 minutes agoon
November 22, 2024By
NEW YORK, Nov. 22, 2024 /PRNewswire/ — Report with market evolution powered by AI – The optometry software market in north america size is estimated to grow by USD 576.62 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.67% during the forecast period. Increasing prevalence of ophthalmic diseases is driving market growth, with a trend towards growing ophthalmology market. However, rising medical data privacy concerns poses a challenge.Key market players include Barti, Compulink Healthcare Solutions, Doctorsoft Corp., EssilorLuxottica, EverCommerce Inc., Eye Care Leaders, First Insight Corp., Health Innovation Technologies Inc., iTRUST.IO LLC , LiquidEHR Inc., MacPractice, Nextech Systems LLC, Optical POS Software LLC, Optometric Services Inc., Solutionreach Inc., SOTH Inc., Vision Service Plan, Weave Communications Inc., WINK Technologies Inc., and WRS Health.
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF
Optometry Software Market In North America Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 6.67%
Market growth 2024-2028
USD 576.62 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
6.32
Regional analysis
North America
Performing market contribution
North America at 100%
Key countries
US, Canada, Mexico, and North America
Key companies profiled
Barti, Compulink Healthcare Solutions, Doctorsoft Corp., EssilorLuxottica, EverCommerce Inc., Eye Care Leaders, First Insight Corp., Health Innovation Technologies Inc., iTRUST.IO LLC , LiquidEHR Inc., MacPractice, Nextech Systems LLC, Optical POS Software LLC, Optometric Services Inc., Solutionreach Inc., SOTH Inc., Vision Service Plan, Weave Communications Inc., WINK Technologies Inc., and WRS Health
Market Driver
The North American optometry software market is experiencing significant growth due to the rising prevalence of chronic ophthalmological conditions such as glaucoma, dry eye, cataracts, and refractive errors. The aging population is also driving demand for electronic health records (EHR) and cloud-based solutions to manage patient data and records in optometry clinics. AI-based software and mobile applications are trending, offering remote patient monitoring and telehealth services for optometrists. Key players like Eyefinity, Crystal PM, Compulink, Practice Mate, MaximEyes, EyeMD, and others are expanding their offerings through expansions, joint ventures, and acquisitions. Ophthalmologists and optometrists require EHR software for prescription history, IOP measurement, and retinal detachment, uveitis, astigmatism, and other conditions. Hospitals, clinics, and specialist centers are adopting cloud-based EMRs for health records data management.
The North American optometry software market has experienced significant growth over the past decade, fueled by the increasing prevalence of eye diseases and technological advancements in ophthalmology. This sector’s expansion is further heightened focus on research and development among manufacturers, aiming to create innovative treatments. Moreover, rising medical expenses, increasing healthcare spending, and a growing demand for precise therapies are additional factors contributing to the market’s growth during the forecast period. Consequently, the expanding ophthalmology market will necessitate the use of software to manage patient treatment records, medication prescriptions, and information related to glasses, contact lenses, and other eye care solutions.
Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!
Market Challenges
The North American optometry software market is experiencing significant growth due to increasing chronic ophthalmological conditions like glaucoma, dry eye, cataracts, and refractive errors. An aging population and the need for electronic health records (EHR) are key drivers. Optometrists require cloud-based solutions for managing patient data and records, including IOP measurement and prescription history. Telehealth and telemedicine services are essential for remote patient care, with AI-based software aiding in diagnosis. Companies like Eyefinity, Crystal PM, Compulink, Practice Mate, MaximEyes, EyeMD, and others are expanding through joint ventures, acquisitions, and strategic expansions. Ophthalmologists also use EHR software for managing complex cases, such as retinal detachment and uveitis. Hospitals, clinics, and specialist centers adopt cloud-based EMRs for health records data management. Mobile applications are also popular for patient engagement and convenience.The optometry software market in North America is witnessing significant growth due to the adoption of advanced technologies for managing medical records and data. However, this trend raises concerns regarding data privacy. Strict regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the US, mandate that personal medical data be kept confidential and only accessible with proper authorization. Despite these regulations, the increasing use of optometry software solutions in ophthalmology necessitates continued vigilance to protect sensitive patient information. It is essential for optometry practices to prioritize data security and ensure compliance with relevant privacy laws to maintain trust with their patients.
Discover how AI is revolutionizing market trends- Get your access now!
Segment Overview
This optometry software market in North America report extensively covers market segmentation by
Type1.1 Cloud-based1.2 Web-basedEnd-user2.1 Hospitals2.2 Nursing homes2.3 OthersGeography3.1 North America
1.1 Cloud-based- The optometry software market in North America is experiencing growth, with a particular focus on cloud-based deployment solutions. These solutions offer benefits such as quick deployment, flexibility, scalability, real-time data visibility, and customization capabilities. Cloud-based deployment enables integration with other eyecare software solutions, including online booking and payment processing. Flexible payment options, like monthly subscriptions and pay-as-you-go models, make these solutions cost-effective. Small and medium-scale eyecare organizations are adopting cloud-based software due to its scalability and cost savings. Innovations in data security will further increase adoption by large-scale enterprises. Cloud-based solutions provide optimal cost and efficiency by allowing organizations to store critical data on-premise and infrequently used data on a public cloud server. The market growth is driven by these advantages, with the cloud-based deployment segment expected to grow at a higher Compound Annual Growth Rate (CAGR) than on-premise deployment during the forecast period.
Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics
Research Analysis
The optometry software market in North America is experiencing significant growth due to the increasing prevalence of chronic ophthalmological conditions such as glaucoma, dry eye, cataracts, and refractive errors. With an aging population, there is a greater need for electronic health records (EHR) and cloud-based solutions to manage patient data and records in optometry clinics, hospitals, specialist centers, and ambulatory settings. Telehealth, telemedicine services, and AI-based software are also gaining popularity for remote patient consultations and diagnosis. Eyefinity, Crystal PM, Compulink, Inpatient EHR, Ambulatory EHR, Maxim Eyes, Revolution EHR, Doctor soft, and Liquid EHR are some of the leading optometry software solutions providing cloud-based EMR and health records data management services. These software solutions enable optometrists to streamline their workflows, improve patient care, and enhance overall operational efficiency.
Market Research Overview
The optometry software market in North America is experiencing significant growth due to the increasing prevalence of chronic ophthalmological conditions such as glaucoma, dry eye, cataracts, and refractive errors in the aging population. Electronic health records (EHR) and cloud-based solutions are becoming increasingly popular, enabling optometrists to manage patient data and records more efficiently. Telehealth and telemedicine services are also gaining traction, allowing for remote patient consultations and monitoring. AI-based software is being integrated into optometry practices to enhance diagnosis and treatment, particularly for conditions like retinal detachment, uveitis, and astigmatism. Optometry clinics, hospitals, specialist centers, and ambulatory care facilities are adopting cloud-based EMR systems to streamline operations and improve patient care. Key trends include expansions, joint ventures, and acquisitions by major players in the market, including Eyefinity, Crystal PM, Compulink, Practice Mate, MaximEyes, EyeMD, and others. IOP measurement and prescription history are critical features of optometry software, ensuring accurate and up-to-date patient information. Overall, the North American optometry software market is poised for continued growth as technology advances and healthcare providers seek to improve patient care and outcomes.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
TypeCloud-basedWeb-basedEnd-userHospitalsNursing HomesOthersGeographyNorth America
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/north-americas-optometry-software-market-to-grow-by-usd-576-62-million-2024-2028-driven-by-rising-ophthalmic-disease-cases-ai-redefining-market-landscape—technavio-302313504.html
SOURCE Technavio
Technology
Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes
Published
42 minutes agoon
November 22, 2024By
PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ — Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time.
“We’re excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well,” said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross. “We expect the platform to transform how we coordinate care for our members with automatic sharing of information with our members’ doctors. There are also anticipated cost savings to both IBX and the health systems and providers on the platform due to decreasing administrative burden, avoiding unnecessary admissions and emergency department visits, and improving preventive care.”
Some key improvements that IBX expects to see in the not-so-distant future from this implementation include:
Fewer care gaps. The real-time exchange of clinical data helps IBX and its network close care gaps, enhancing member health understanding and improving care quality.More insight into members’ health. IBX and its network can access synchronized clinical information in real-time, enhancing healthcare team collaboration and improving patient care strategies and outcomes.Reduced administrative burden. The Epic Payer Platform will make it easier and quicker for IBX and the health systems and providers in its network to communicate and share information, lessening the need for manual exchange of information.Enhanced medication cost transparency. Health Systems and providers will have real-time access to benefits information for IBX members. This will help them have meaningful discussions with patients about how much prescribed medications will cost members and, in some cases, suggest lower-cost alternatives if they are available.Comprehensive patient care journey data. Providing participating health systems and providers with complete and accurate population health analytics to inform health care providers.
“The integration of the Epic Payer Platform with Independence Blue Cross will significantly enhance our ability to provide comprehensive and efficient care to our patients, ensuring better health outcomes and streamlined operations,” said John S. Potts, DO, FAAFP, assistant chief medical information officer at Main Line Health.
In the long-term future, IBX expects its use of Epic Payer Platform to lead to automating prior authorization requests and updates, improving efficiency and reducing delays. Other activities that IBX anticipates happening in the future include:
Allowing health systems and providers to verify in-network status and access cost/quality ratings, increasing patient satisfaction and optimizing value-based care.Eliminating the need for manual scanning of physical insurance cards by providing digital ID card access.
“We are excited to modernize our partnership with Independence Blue Cross via their Epic Payer Platform integration. These efforts aim to improve patient health outcomes, reduce provider burden, and grow digitally shared patient data,” Nathalie S. May, MD, FACP, professor of medicine and chief quality officer at Drexel University College of Medicine.
IBX is working with health systems and providers in the region who are already utilizing Epic’s EHR system to implement the platform in a phased approach. This implementation of Epic Payer Platform complements IBX’s existing work with HealthShare Exchange, a platform that allows health insurers and different types of providers (e.g., community providers, health systems, community-based organizations, etc.), who may or may not use Epic, to share clinical records to make patient care more informed.
Member privacy and confidentiality is a top priority for IBX. IBX is working with Epic to safeguard clinical information utilizing physical, administrative, and technical safeguards as required by HIPAA.
About Independence Blue Cross:
Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. For more than 85 years, we have been enhancing the health and well-being of the people and communities we serve. We deliver innovative and competitively priced health care products and services; pioneer new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and support programs and events that promote wellness. To learn more, visit ibx.com. Connect with us on Facebook, LinkedIn, and Instagram. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
CONTACT: Diana Quattrone
215-815-7828 (cell)
Diana.Quattrone@ibx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/independence-blue-cross-launches-epic-payer-platform-to-transform-care-coordination-and-boost-member-health-outcomes-302314517.html
SOURCE Independence Blue Cross
Technology
RealDefense Ranked a Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Published
42 minutes agoon
November 22, 2024By
RealDefense’s 267% Revenue Growth Driven by Consistent Product Innovation and Strategic Partner Ecosystem Expansion
PASADENA, Calif., Nov. 22, 2024 /PRNewswire-PRWeb/ — RealDefense today announced its inclusion in the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. RealDefense grew 267% during this period.
Gary Guseinov, CEO of RealDefense, and Sean Whiteley, President, attribute this growth to acquisition synergies, organic growth, and the scalability of our partner platform. “Together, these factors have enabled us to scale efficiently, meet rising market demand, and deliver strong financial performance. This recognition reflects RealDefense’s continued focus on driving innovation and growth across our expanding ecosystem, setting the stage for even greater success in the future,” said Guseinov.
“Innovation, transformation and disruption of the status quo are at the forefront for this year’s Technology Fast 500 list, and there’s no better way to celebrate 30 years of program history,” said Christie Simons, partner, Deloitte & Touche LLP and industry leader for technology, media and telecommunications within Deloitte’s Audit & Assurance practice. “This year’s winning companies have demonstrated a continuous commitment to growth and remarkable consistency in driving forward progress. We extend our congratulations to all of this year’s winners — it’s an incredible time for innovation.”
About the 2024 Deloitte Technology Fast 500
Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2020 to 2023.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
About RealDefense
Headquartered in Pasadena, CA, RealDefense LLC is an award-winning software development company known for its flagship product brands, including iolo System Mechanic® and SUPERAntiSpyware®. With a commitment to innovation, RealDefense has consistently earned top ratings from PC Magazine™ and protects over 3 million customers. The RealDefense portfolio features renowned privacy and security software brands such as STOPzilla, MyCleanID, MyCleanPC, USTechSupport, ioloVPN, GetMyDrivers, WarrantyStar, and Support.com.
RealDefense partners with leading consumer brands in the cyber security and PC manufacturing sectors to deliver telemetry-enabled monetization solutions. For more information, please visit www.realdefen.se.
About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte’s approximately 460,000 people worldwide connect for impact at www.deloitte.com.
Media Contact
PR, RealDefense, 1 (626) 605-0277, pr@realdefen.se, www.realdefen.se
View original content to download multimedia:https://www.prweb.com/releases/realdefense-ranked-a-fastest-growing-company-in-north-america-on-the-2024-deloitte-technology-fast-500-302313801.html
SOURCE RealDefense
North America’s Optometry Software Market to Grow by USD 576.62 Million (2024-2028), Driven by Rising Ophthalmic Disease Cases, AI Redefining Market Landscape – Technavio
Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes
RealDefense Ranked a Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Near Videos4 days ago
AI Agents Powered by NEAR: Decentralized, Secure, and Live Now! 🤖
-
Near Videos4 days ago
How LLMs and Smart Contracts Are Changing the Game
-
Near Videos4 days ago
AI in Crypto: Due Diligence & On-Chain Security 🔍
-
Technology5 days ago
Boehringer Ingelheim Commits to Veeva Vault CRM
-
Coin Market4 days ago
Polter hit by flash loan attack, man gets 24 years for scam: Crypto-Sec
-
Coin Market4 days ago
Japan’s DMM Crypto shuts down Seamoon Protocol amid challenges
-
Coin Market4 days ago
ai16z token rockets 50% after nod from top venture firm
-
Coin Market4 days ago
Coinbase CEO to meet with Trump to discuss personnel appointments — WSJ